Inventor · disambiguated record
Katalin Varadi
Also filed as: VARADI KATALIN
20 granted patents·3 pending applications·103 citations·filing 1995–2019
94Inventor score
Top patents by PatentIndex Score
23 records- 0194US8623612B2Method for testing treatment of ADAMTS13 deficiencyBAXTER INT·Filed 2013·Granted Jan 7, 2014·10 cites·21 claims
- 0293US9110085B2Methods of testing effectiveness of a treatment for thromobotic thrombocytopenic purpura by measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factorBAXTER INT·Filed 2013·Granted Aug 18, 2015·8 cites·17 claims
- 0392US10209263B2Methods of measuring adamts 13 activityBAXALTA INC·Filed 2016·Granted Feb 19, 2019·5 cites·32 claims
- 0492US7683158B2Pegylated factor VIIIBAXTER INT·Filed 2007·Granted Mar 23, 2010·16 cites·9 claims
- 0588US9488651B2Methods of measuring ADAMTS 13 activityBAXALTA INC·Filed 2014·Granted Nov 8, 2016·3 cites·18 claims
- 0686US8415114B2Methods of measuring ADAMTS13-mediated in vivo cleavage of von Willebrand factor and uses thereofVARADI KATALIN·Filed 2009·Granted Apr 9, 2013·8 cites·18 claims
- 0777US8557534B2Method and compositions for specifically detecting physiologically acceptable polymer moleculesTURECEK PETER·Filed 2008·Granted Oct 15, 2013·4 cites·14 claims
- 0875US10900979B2Methods for testing effectiveness of a von Willebrand factor used in treating von Willebrand disease (VWD)Baxalta GmbH·Filed 2019·Granted Jan 26, 2021·0 cites·23 claims
- 0973US8133865B2von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkageBOSSARD MARY J·Filed 2007·Granted Mar 13, 2012·1 cites·27 claims
- 1072US7557188B2Methods of treating blood coagulation disorders using a pharmaceutical preparation comprising vWF propeptideBAXTER INNOVATIONS GMBH·Filed 2005·Granted Jul 7, 2009·1 cites·7 claims
- 1171US9547016B2Method and compositions for specifically detecting physiologically acceptable polymer moleculesBAXALTA INC·Filed 2013·Granted Jan 17, 2017·1 cites·20 claims
- 1270US7005502B1Pharmaceutical preparation comprising vWF propeptideBAXTER AG·Filed 1998·Granted Feb 28, 2006·24 cites·5 claims
- 1361US8349800B2Von Willebrand factor- and factor VIII-polymer conjugates having a releasable linkageNEKTAR THERAPEUTICS·Filed 2012·Granted Jan 8, 2013·0 cites·20 claims
- 1460US9493544B2Von willebrand factor- and factor VIII-polymer conjugates having a releasable linkageBOSSARD MARY J·Filed 2012·Granted Nov 15, 2016·0 cites·20 claims
- 1560US2017227557A1Method and compositions for specifically detecting physiologically acceptable polymer moleculesBAXALTA INC·Filed 2017·Application pending·0 cites
- 1655US9274122B2Methods for determining active ingredients in pro-drug PEG protein conjugates with releasable PEG reagents (in vitro de-pegylation)VARADI KATALIN·Filed 2009·Granted Mar 1, 2016·0 cites·19 claims
- 1754US2014232029A1Kit for measuring the thrombin generation in a sample of a patient's blood or plasmaBAXTER INT·Filed 2014·Application pending·0 cites
- 1851US8735086B2Kit for measuring the thrombin generation in a sample of a patient's blood or plasmaVARADI KATALIN·Filed 2012·Granted May 27, 2014·0 cites·10 claims
- 1951US8053561B2Pegylated factor VIIIBAXTER INT·Filed 2010·Granted Nov 8, 2011·0 cites·21 claims
- 2049US5804181APharmaceutical preparation for the prevention and treatment of blood coagulation disordersIMMUNO AG·Filed 1995·Granted Sep 8, 1998·7 cites·15 claims
- 2144US5643739AAssay for determining sensitivity to activated protein CIMMUNO AG·Filed 1995·Granted Jul 1, 1997·12 cites·18 claims
- 2244US2005221414A1Kit for measuring the thrombin generation in a sample of a patient's blood or plasmaVARADI KATALIN·Filed 2004·Application pending·0 cites
- 2326US5863896AEvaluation of substances for altering and for increasing APC responseIMMUNO AG·Filed 1995·Granted Jan 26, 1999·3 cites·21 claims
Join the waitlist — get patent alerts
Get an alert when Katalin Varadi files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →